Russ Swan, Editor, writes:
We see from your search that you're looking for information on the term "Drug Discovery Companies",
and we have a large number of manufacturers' news releases and technical articles here on Laboratorytalk which will be of interest.
Let me be your guide.
Start with
the news release Omix emerges as de facto informatics platform from
Genologics, which we summarised at the time by saying "GenoLogics says that a growing number of leading-edge research and discovery organisations have chosen its lab informatics platform, Omix, to enable their translational medicine
initiatives".
Several months prior to that,
we featured the news release More kinase assay kits for drug discovery from
Chemicon International: "Serologicals says that Upstate Group, its wholly owned subsidiary, has expanded its Kinease FP product line to include each of the 80 individual kinases that have been validated in the assay".
In July 2006, we covered the news from Chemicon International
concerning its Visualizer EC western blot kit
- take a look at More cost efficient Western blotting detection
which says: "Serologicals announced that Upstate, its subsidiary, has released a new, more cost efficient Western blotting detection kit based on its high quality Visualizer western blot detection kit".
Take a look also at the news release from Frost and Sullivan, Use of computational biology tools is set to grow,
as well as Analysis of cell-based assays market in Europe from Frost and Sullivan,
and Analysis of global biopharmaceutical manufacturing from Frost and Sullivan.
See also:
A 'natural alliance' for drug discovery
(November 2004)
Natural products are central to a new drug discovery alliance announced by LGC and Novacta Biosystems
LGC and ChemOvation announce collaboration
(May 2004)
LGC's expertise in biomeasurement and its extensive capabilities in cell-based testing create a natural link with Chemovation's offering in the drug discovery market
Instrument integration in pharmaceutical QA labs
(April 2004)
Costs and benefits, plus some potential pitfalls, of establishing an integreated system linking instruments to laboratory information management systems and other technologies is explored
Teamwork to boost drug development services
(March 2004)
LGC links with Akos, a specialist drug development and regulatory affairs consultancy company, to enable both to expand the range of services they offer to drug discovery companies
More flexibility in high content screening
(January 2004)
Access plan provides scientists performing high content screening with a more flexible and economical way to purchase and utilise applications
Swift, sure sample supply
(August 2003)
Sample management software suite tracks compounds and reagents, and manages the processes that prepare them for drug screening
New deals on microplate reader
(August 2003)
Merger means a 'highly competitive entry price point' for a laser-scanning fluorescence microplate reader
Helping hand for drug discovery companies
(September 2002)
How does a growing biotechnology company get advice from expert medicinal chemists without setting up its own facility?